Dhanvantri Jeevan Rekha Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison
Dhanvantri Jeevan Rekha Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Dhanvantri Jeevan Rekha Ltd is ₹ 23.56 as of 23 Oct 15:30
. The P/E Ratio of Dhanvantri Jeevan Rekha Ltd changed from 14.1 on March 2022 to 26.7 on March 2026 . This represents a CAGR of 13.62% over 5 yearsThe P/E Ratio of Global Longlife Hospital and Research Ltd changed from 25.7 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 years The Market Cap of Dhanvantri Jeevan Rekha Ltd changed from ₹ 3.06 crore on March 2021 to ₹ 10.3 crore on March 2026 . This represents a CAGR of 22.42% over 6 yearsThe Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 47.02 crore on March 2023 to ₹ 14.34 crore on March 2026 . This represents a CAGR of -25.69% over 4 years The revenue of Dhanvantri Jeevan Rekha Ltd for the Jun '26 is ₹ 7.87 crore as compare to the Mar '26 revenue of ₹ 7.34 crore. This represent the growth of 7.22% The revenue of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Dhanvantri Jeevan Rekha Ltd for the Jun '26 is ₹ 0.36 crore as compare to the Mar '26 ebitda of ₹ 0.49 crore. This represent the decline of -26.53% The ebitda of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Dhanvantri Jeevan Rekha Ltd changed from ₹ 0.16 crore to ₹ 0.18 crore over 9 quarters. This represents a CAGR of 5.37%
The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0%
The Dividend Payout of Dhanvantri Jeevan Rekha Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Dhanvantri Jeevan Rekha Ltd
Dhanvantri Jeevan Rekha Limited, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services.
Dhanvantri Hospital with advance and high-class patient care, made humble beginning around 30 years ago in 1993 at 1- Saket, Meerut.
The Hospital has grown in becoming a major healthcare provider to all walks of life in Meerut and the surrounding region.
The Company was incorporated as a Public Limited Company with the Registrar of Companies in Uttar Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging (MRI).
It obtained Certificate for Commencement of Business on August 2, 1993.
In October 1993, the Company acquired a constructed building at Saket, in Meerut for establishing the Diagnostic Centre.
About Global Longlife Hospital and Research Ltd
Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021.
The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution in Ahmedabad.
Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.
FAQs for the comparison of Dhanvantri Jeevan Rekha Ltd and Global Longlife Hospital and Research Ltd
Which company has a larger market capitalization, Dhanvantri Jeevan Rekha Ltd or Global Longlife Hospital and Research Ltd?
Market cap of Dhanvantri Jeevan Rekha Ltd is 9 Cr while Market cap of Global Longlife Hospital and Research Ltd is 13 Cr
What are the key factors driving the stock performance of Dhanvantri Jeevan Rekha Ltd and Global Longlife Hospital and Research Ltd?
The stock performance of Dhanvantri Jeevan Rekha Ltd and Global Longlife Hospital and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Dhanvantri Jeevan Rekha Ltd and Global Longlife Hospital and Research Ltd?
As of October 25, 2026, the Dhanvantri Jeevan Rekha Ltd stock price is INR ₹23.56. On the other hand, Global Longlife Hospital and Research Ltd stock price is INR ₹12.57.
How do dividend payouts of Dhanvantri Jeevan Rekha Ltd and Global Longlife Hospital and Research Ltd compare?
To compare the dividend payouts of Dhanvantri Jeevan Rekha Ltd and Global Longlife Hospital and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.